Clinical Trial Update: xDRIVE in Metastatic Colorectal Cancer

View source ↗

Summary

The clinical trial update indicates the xDRIVE therapy for metastatic colorectal cancer is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma
• Colon Cancer
• Colorectal Cancer
• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• xDRIVE

Snippet

Sponsor: First Ascent Biomedical Inc. | Conditions: Metastatic Colon Adenocarcinoma, Metastatic Colon Cancer | Status: NOT_YET_RECRUITING